IVRO

Healthcare Diagnostics & Research

InVitro International, Inc.

$0.06
+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap
1.34M
Avg Volume
9,316
52W High
$0.16
52W Low
$0.03
Div. Yield
0.0%

Valuation

P/B Ratio
0.87
P/S Ratio
1.65
EV/EBITDA
14.13
EV/Revenue
1.27

Margins

Gross Margin 80.6%
Operating Margin 6.0%
Net Margin 13.2%
EBITDA Margin 9.0%

Growth & Returns

Revenue Growth (YoY)
(12.9%)
Earnings Growth (YoY)
48.8%
Earnings Growth (QoQ)
48.8%
Return on Equity
7.1%
Return on Assets
2.5%

Liquidity & Leverage

Current Ratio
16.69
Quick Ratio
14.18
Total Cash
332,665
Total Debt
0

About

InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a biomembrane and chemical detection systems. The company also provides customized technology services for Irritection Assay System installation and testing process, and independent testing laboratory services for irritancy and corrosivity testing requirements, as well as consultation and assistance services. Its products are principally used in cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation industries. InVitro International, Inc. was incorporated in 1985 and is headquartered in Placentia, California.

www.invitrointl.com